CNIO Arte en ARCO 2024 CNIO Arte 2024 Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Evaluation of type I interferon pathway in KRAS-driven lung adenocarcinoma and its potential synergy with immunotherapy

Evaluation of type I interferon pathway in KRAS-driven lung adenocarcinoma and its potential synergy with immunotherapy

Información

Fecha: 06/07/2023
Hora 10:00
Lugar: Auditorio CNIO
Conferenciante Fernando Fernández García
Procedencia Experimental Oncology Group, Molecular Oncology Programme
Supervised by Director Mariano Barbacid and co-director Monica Musteanu, Experimental Oncology Group Molecular Oncology Programme
Entrada libre hasta completar aforo

Subir